$2.59T
Total marketcap
$166.74B
Total volume
BTC 50.11%     ETH 15.76%
Dominance

Vaxcyte PCVX Stock

68.04 USD {{ price }} -2.381630% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
7.38B USD
LOW - HIGH [24H]
67.92 - 69.93 USD
VOLUME [24H]
682.28K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.14 USD

Vaxcyte Price Chart

Vaxcyte PCVX Financial and Trading Overview

Vaxcyte stock price 68.04 USD
Previous Close 52.4 USD
Open 52.3 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 51.76 - 52.59 USD
52 Week Range 18.91 - 54.84 USD
Volume 400.51K USD
Avg. Volume 946K USD
Market Cap 4.89B USD
Beta (5Y Monthly) 0.956114
PE Ratio (TTM) N/A
EPS (TTM) -4.14 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 66.29 USD

PCVX Valuation Measures

Enterprise Value 4.08B USD
Trailing P/E N/A
Forward P/E -15.564179
PEG Ratio (5 yr expected) -14.5
Price/Sales (ttm) N/A
Price/Book (mrq) 4.4503245
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -15.603

Trading Information

Vaxcyte Stock Price History

Beta (5Y Monthly) 0.956114
52-Week Change 158.24%
S&P500 52-Week Change 20.43%
52 Week High 54.84 USD
52 Week Low 18.91 USD
50-Day Moving Average 46.95 USD
200-Day Moving Average 40.64 USD

PCVX Share Statistics

Avg. Volume (3 month) 946K USD
Avg. Daily Volume (10-Days) 464.37K USD
Shares Outstanding 93.71M
Float 82.88M
Short Ratio 8.99
% Held by Insiders 4.07%
% Held by Institutions 90.54%
Shares Short 7.07M
Short % of Float 8.52%
Short % of Shares Outstanding 7.53%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -23.41%
Return on Equity (ttm) -37.56%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -22995000 USD
EBITDA -261520000 USD
Net Income Avi to Common (ttm) -244960992 USD
Diluted EPS (ttm) -3.4
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 822.04M USD
Total Cash Per Share (mrq) 8.77 USD
Total Debt (mrq) 16.59M USD
Total Debt/Equity (mrq) 1.76 USD
Current Ratio (mrq) 15.938
Book Value Per Share (mrq) 11.716

Cash Flow Statement

Operating Cash Flow (ttm) -190584992 USD
Levered Free Cash Flow (ttm) -120237128 USD

Profile of Vaxcyte

Country United States
State CA
City San Carlos
Address 825 Industrial Road
ZIP 94070
Phone 650 837 0111
Website https://vaxcyte.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 158

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against these emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Q&A For Vaxcyte Stock

What is a current PCVX stock price?

Vaxcyte PCVX stock price today per share is 68.04 USD.

How to purchase Vaxcyte stock?

You can buy PCVX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Vaxcyte?

The stock symbol or ticker of Vaxcyte is PCVX.

Which industry does the Vaxcyte company belong to?

The Vaxcyte industry is Biotechnology.

How many shares does Vaxcyte have in circulation?

The max supply of Vaxcyte shares is 108.41M.

What is Vaxcyte Price to Earnings Ratio (PE Ratio)?

Vaxcyte PE Ratio is now.

What was Vaxcyte earnings per share over the trailing 12 months (TTM)?

Vaxcyte EPS is -4.14 USD over the trailing 12 months.

Which sector does the Vaxcyte company belong to?

The Vaxcyte sector is Healthcare.

Vaxcyte PCVX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1454.2 USD
-0.47
1453.71 USD 1464.83 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD